Actuate Therapeutics Inc. (ACTU) Live Share Price, Invest From India

Actuate Therapeutics Inc. Stock Performance

as on June 19, 2026 at 2:16 pm IST

Day's Low
Day's High
$1.95
Day's Price Range
$2.15
$2.07
5.80%
Downside
3.86%
Upside
52 Week's Low
52 Week's High
$1.58
52-Week Price Range
$9.22
$2.07
23.67%
Downside
345.41%
Upside

Actuate Therapeutics Inc. share price movements today

Previous Close: $2.05
Open: $2.11
Volume: 193.4K
Day's Low - High: $1.95 - $2.15
52 Week Low - High: $1.58 - $9.22

Actuate Therapeutics Inc. Historical Returns

1 Month Return: -13.75 %
3 Month Return: -17.2 %
1 Year Return: -72.36 %
3 Year Return: 0 %
5 Year Return: 0 %

Actuate Therapeutics Inc. Stock Fundamentals & Key Indicators

Check Actuate Therapeutics Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$49.0M

EPS (TTM)

-0.7767

Dividend Yield

0.00%

PE Ratio (TTM)

PEG Ratio

Return On Equity TTM

-553.75%

Actuate Therapeutics Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Actuate Therapeutics Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Actuate Therapeutics Inc.	NA	$49.0M	NA	NA	0.00%	NA
Alnylam Pharmaceuticals Inc.	BUY	$37.7B	57.21%	71.21	12.55%	NA
Vertex Pharmaceuticals Inc.	BUY	$116.5B	140.42%	27.22	35.51%	NA
Regeneron Pharmaceuticals Inc.	BUY	$63.7B	13.39%	14.85	29.65%	0.58%

Stock Returns calculator for Actuate Therapeutics Inc. Stock including INR - Dollar returns

The Actuate Therapeutics Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Actuate Therapeutics Inc. investment value today

Current value as on today

₹30,014

Returns

-₹69,986

(-69.99%)

Returns from Actuate Therapeutics Inc. Stock

-₹72,363 (-72.36%)

Dollar Impact

₹2,377 (+2.38%)

Indian Investors' Interest in Actuate Therapeutics Inc. Stock

Search interest for Actuate Therapeutics Inc. Stock has decreased by -4% in the last 30 days, reflecting a downward trend in search activity.

Time period: May 21, 2026 to June 20, 2026

Change:-4% versus previous 30 day period

Actuate Therapeutics Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Revenue	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-
Operating Income	-7	-7	-5	-5	-6	-6	-5	-5	-4	-5
EBITDA	-7	-8	-6	-5	-6	-6	-5	-5	-4	-5
Interest Expense	0	0	0	0	0	0	0	0	0	0
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-7	-8	-6	-5	-6	-6	-5	-5	-4	-5
Income Tax Expense	-	-	-	-	-	-	-	-	0	-
Net Income	-7	-8	-6	-5	-6	-6	-5	-5	-4	-5
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Actuate Therapeutics Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	-	-
Gross Profit	-	-	-	-
Operating Income	-20	-24	-25	-22
EBITDA	-20	-24	-25	-22
Interest Expense	0	0	0	0
Depreciation	-	-	-	-
Income Before Tax	-20	-24	-27	-22
Income Tax Expense	-	-	0	0
Net Income	-20	-24	-27	-22
Net Profit Margin	0.00%	0.00%	0.00%	0.00%

Actuate Therapeutics Inc. Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Net Income	-8	-6	-5	-6	-6	-5	-5	-4	-5
Operating Cash Flow	-5	-2	-9	-4	-4	-4	-6	-3	-5
Investing Cash Flow	-	-	-	-	-	-	-	-	-
Financing Cash Flow	4	0	22	0	0	6	17	0	0
Change in Cash	0	-1	13	-4	-4	2	10	-3	-5

Actuate Therapeutics Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2023	Dec 2024	Dec 2025
Net Income	-24	-27	-22
Operating Cash Flow	-21	-21	-19
Investing Cash Flow	-	-	-
Financing Cash Flow	4	27	23
Change in Cash	-17	5	4

Global Institutional Holdings in Actuate Therapeutics Inc.

Funds	Holdings
Geode Capital Management, LLC	0.95%
Sfmg LLC	0.14%
Royal Bank of Canada	0.09%
Northwestern Mutual Wealth Management Co	0.13%
Voss Capital LLC	7.21%

See all

Insights on Actuate Therapeutics Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, Regeneron Pharmaceuticals, Inc. Common Stock has given 19.7% return, outperforming this stock by 92.0%
NEGATIVE IMPACT
Price Dip
In the last 1 month, ACTU stock has moved down by -17.5%

About Actuate Therapeutics Inc.

Actuate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancers in the United States. The company's lead product candidate is elraglusib injection, a glycogen synthase kinase-3 inhibitor that is in Phase 2 trial to treat metastatic pancreatic ductal adenocarcinoma. It also develops elraglusib, which is in Phase 1/2 trial for the treatment of refractory pediatric malignancies, including Ewing sarcoma, as well as neuroblastoma and pediatric leukemias. The company was formerly known as Apotheca Therapeutics, Inc. and changed its name to Actuate Therapeutics, Inc. in October 2015. Actuate Therapeutics, Inc. was incorporated in 2015 and is headquartered in Fort Worth, Texas.

Organisation	Actuate Therapeutics Inc.
Headquarters	1751 River Run, Fort Worth, TX, United States, 76107
Industry	Biotechnology
CEO	Mr. Daniel M. Schmitt
E-voting on shares	Click here to vote

Key Management of Actuate Therapeutics Inc.

Name	Title
Mr. Daniel M. Schmitt	CEO, President & Director
Dr. Andrew P. Mazar Ph.D.	Co-Founder & COO
Mr. Paul J. Lytle CPA	Chief Financial Officer
Dr. Alan Kozikowski Ph.D.	Scientific Founder and Advisor

FAQs

What is Actuate Therapeutics Inc. share price today?

Actuate Therapeutics Inc. share price today is $2.07 as on June 19, 2026 at 8:46 am IST at the close of the market. Actuate Therapeutics Inc. share today touched a day high of $2.15 and a low of $1.95.

What is the 52 week high and 52 week low for Actuate Therapeutics Inc. share?

Actuate Therapeutics Inc. share touched a 52 week high of $9.22 on September 4, 2025 and a 52 week low of $1.58 on April 13, 2026. Actuate Therapeutics Inc. stock price today i.e. June 19, 2026 at 8:46 am IST is closed at $2.07,which is 77.55% down from its 52 week high and 31.01% up from its 52 week low.

What is Actuate Therapeutics Inc.'s market capitalisation today?

Actuate Therapeutics Inc. market capitalisation is $0.00T as on June 19, 2026 at 8:46 am IST.

How to invest in Actuate Therapeutics Inc. Stock (ACTU) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Actuate Therapeutics Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Actuate Therapeutics Inc. Shares that will get you 0.7246 shares as per Actuate Therapeutics Inc. share price of $2.07 per share as on June 19, 2026 at 8:46 am IST.

What is the minimum amount required to buy Actuate Therapeutics Inc. Stock (ACTU) from India?

Indian investors can start investing in Actuate Therapeutics Inc. (ACTU) shares with as little as ₹94.31 or $1 (as of June 20, 2026 at 8:43 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹943.10 in Actuate Therapeutics Inc. stock (as per the Rupee-Dollar exchange rate as on June 20, 2026 at 8:43 pm IST). Based on Actuate Therapeutics Inc. share’s latest price of $2.07 as on June 19, 2026 at 8:46 am IST, you will get 4.8309 shares of Actuate Therapeutics Inc.. Learn more about fractional shares .